We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Kit Provides Quantitative Determination of Haptoglobin in Human Serum

By LabMedica International staff writers
Posted on 27 Jan 2011
A new liquid stable haptoglobin kit provides a highly sensitive and specific method for the quantitative determination of haptoglobin in human serum.

The method is fully automated and suitable for use on the RX series of bench top clinical analyzers including the RX daytona and RX imola. More...
Liquid, ready-to-use quality controls and calibrators are also available. Liquid specific protein controls are stable for 30 days at 2 °C to 8 °C and are 100% human in origin. Three clinically significant levels are available with assayed target values and ranges for 27 different analytes including haptoglobin.

A product of Randox (Crumlin, UK) the haptoglobin assay is based on an immunoturbidimetric method where haptoglobin in the sample is diluted and reacted with specific antiserum, yielding insoluble aggregates that can be measured turbidimetrically at 340 nm.

A wide measuring range of 0.13 g/L to 3.68 g/L ensures that the assay is capable of accurately measuring above and below the patient normal range while an extended onboard stability of 28 days minimizes reagent waste.

The assay is precise, traceable to certified reference material, and has limited interference from bilirubin, hemoglobin, and triglycerides. Prozone effects are not demonstrated up to at least 7.64 g/L and the assay shows excellent correlation to standard methods.

In addition to quality controls, Randox also offers a specific protein EQA program providing customers with a complete quality management solution. The bi-weekly RIQAS program comprises 26 proteins and allows assessment of analytical performance in comparison to other laboratories using the same method/instrument.

Haptoglobin is an acute phase protein made primarily in the liver. Its main function is to bind free hemoglobin and remove it from circulation preventing damage to the kidneys and loss of iron following hemolysis.

Measurements of haptoglobin are mainly used to diagnose hemolytic anemia and to distinguish it from other types of anemia. In cases of hemolytic anemia, haptoglobin levels in the blood decrease significantly. However, low levels may also indicate red blood cell destruction due to sickle cell anemia or thalassemia.

As an acute phase reactant, haptoglobin levels in the blood are significantly increased in response to infection, inflammation, burns, surgery, and trauma, but haptoglobin is not generally used to diagnose or monitor these conditions.

Related Links:

Randox



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
New
All-in-One Molecular System
AIO M160
New
Steam Sterilizer
Hi Vac II Line
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Roche’s CE-Marked Elecsys pTau217 blood test is a single‑assay blood test measures phosphorylated tau 217, an indicator of amyloid pathology and a hallmark of Alzheimer’s disease (image credit: Shutterstock)

Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection

Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read more

Molecular Diagnostics

view channel
Image: Clarifying tumor microenvironment features and cancer-cell programs linked to treatment response could provide earlier insight into triple-negative breast cancer therapy (image credit: Shutterstock)

Gene Panel Shows Promise for Predicting Chemotherapy Response in TNBC

Triple-negative breast cancer (TNBC) is an aggressive subtype commonly treated with chemotherapy, yet outcomes vary widely among patients. Understanding the tumor features that drive this variability remains... Read more

Microbiology

view channel
Image: The initiative combines epidemiological and microbiological data with whole-genome sequencing to characterize circulating hospital lineages and resistance determinants (image credit: Shutterstock)

Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals

Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.